AR079269A1 - PROCEDURE FOR THE PREPARATION OF DRONEDARONA - Google Patents

PROCEDURE FOR THE PREPARATION OF DRONEDARONA

Info

Publication number
AR079269A1
AR079269A1 ARP100104488A ARP100104488A AR079269A1 AR 079269 A1 AR079269 A1 AR 079269A1 AR P100104488 A ARP100104488 A AR P100104488A AR P100104488 A ARP100104488 A AR P100104488A AR 079269 A1 AR079269 A1 AR 079269A1
Authority
AR
Argentina
Prior art keywords
chlorine
general formula
iodine atom
hydroxyl
hydroxyl group
Prior art date
Application number
ARP100104488A
Other languages
Spanish (es)
Inventor
Nagy Marianna Csatarine
Zsolt Dombrady
Antal Friesz
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of AR079269A1 publication Critical patent/AR079269A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80Radicals substituted by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Y los intermediarios del procedimiento de preparacion. Reivindicacion 1: Procedimiento para la preparacion de N-[2-n-butil-3-{4-[(3-dibutilamino)-propoxi]benzoil}-1-benzofuran-5-il]metanosulfonamida de formula (1) y sus sales farmacéuticamente aceptables, caracterizado porque un derivado de benzofurano de formula general (2) donde X representa un átomo de cloro, bromo o yodo, un grupo hidroxilo o hidroxilo activado- se somete a reaccion con dibutilamina y, si se desea, se forma la sal del producto. Reivindicacion 32: Los compuestos de formula general (2) en la cual X es un átomo de cloro, bromo o yodo, un grupo hidroxilo o hidroxilo activado. Reivindicacion 34: Los compuestos de formula general (5) en la cual X es un átomo de cloro, bromo o yodo, un grupo hidroxilo o hidroxilo activado. Reivindicacion 36: Los compuestos de formula general (6) en la cual X es un átomo de cloro o yodo, un grupo hidroxilo o hidroxilo activado.And the intermediaries of the preparation procedure. Claim 1: Process for the preparation of N- [2-n-butyl-3- {4 - [(3-dibutylamino) -propoxy] benzoyl} -1-benzofuran-5-yl] methanesulfonamide of formula (1) and its pharmaceutically acceptable salts, characterized in that a benzofuran derivative of the general formula (2) where X represents a chlorine, bromine or iodine atom, an activated hydroxyl or hydroxyl group - is reacted with dibutylamine and, if desired, the product salt Claim 32: The compounds of the general formula (2) in which X is a chlorine, bromine or iodine atom, an activated hydroxyl or hydroxyl group. Claim 34: The compounds of the general formula (5) in which X is a chlorine, bromine or iodine atom, an activated hydroxyl or hydroxyl group. Claim 36: The compounds of general formula (6) in which X is a chlorine or iodine atom, an activated hydroxyl or hydroxyl group.

ARP100104488A 2009-12-08 2010-12-06 PROCEDURE FOR THE PREPARATION OF DRONEDARONA AR079269A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0900759A HUP0900759A2 (en) 2009-12-08 2009-12-08 Novel process for producing dronedarone

Publications (1)

Publication Number Publication Date
AR079269A1 true AR079269A1 (en) 2012-01-04

Family

ID=89989418

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100104488A AR079269A1 (en) 2009-12-08 2010-12-06 PROCEDURE FOR THE PREPARATION OF DRONEDARONA

Country Status (16)

Country Link
US (2) US8501971B2 (en)
EP (1) EP2509971A1 (en)
JP (1) JP2013512944A (en)
CN (1) CN102741238A (en)
AR (1) AR079269A1 (en)
AU (1) AU2010329655B2 (en)
BR (1) BR112012013753A2 (en)
CA (1) CA2781647A1 (en)
HU (1) HUP0900759A2 (en)
IL (1) IL220170A0 (en)
MX (1) MX2012006654A (en)
RU (1) RU2012128568A (en)
SG (1) SG181562A1 (en)
TW (1) TW201144291A (en)
UY (1) UY33094A (en)
WO (1) WO2011070380A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0900759A2 (en) * 2009-12-08 2011-11-28 Sanofi Aventis Novel process for producing dronedarone
IT1398317B1 (en) * 2010-02-23 2013-02-22 Chimico Internaz Spa Lab NEW PROCEDURE FOR DRONEDARONE PREPARATION.
FR2957079B1 (en) 2010-03-02 2012-07-27 Sanofi Aventis PROCESS FOR THE SYNTHESIS OF CETOBENZOFURAN DERIVATIVES
FR2958290B1 (en) 2010-03-30 2012-10-19 Sanofi Aventis PROCESS FOR THE PREPARATION OF SULFONAMIDO-BENZOFURAN DERIVATIVES
FR2958291B1 (en) 2010-04-01 2013-07-05 Sanofi Aventis PROCESS FOR PREPARING AMINO-BENZOFURAN DERIVATIVES
HUP1000330A2 (en) 2010-06-18 2011-12-28 Sanofi Sa Process for the preparation of dronedarone and the novel intermediates
WO2012004658A2 (en) * 2010-07-09 2012-01-12 Frichem Private Limited Process for preparation of n-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-5-benzofuranyl]methanesulfonamide, acid addition salts and product thereof
FR2962731B1 (en) 2010-07-19 2012-08-17 Sanofi Aventis PROCESS FOR THE PREPARATION OF AMINO-BENZOYL-BENZOFURAN DERIVATIVES
FR2963006B1 (en) 2010-07-21 2013-03-15 Sanofi Aventis PROCESS FOR THE PREPARATION OF NITRO-BENZOFURAN DERIVATIVES
HUP1000386A2 (en) 2010-07-22 2012-05-29 Sanofi Sa Novel process for producing dronedarone
WO2012032545A1 (en) 2010-09-08 2012-03-15 Cadila Healthcare Limited Processes for preparing dronedarone and its intermediates
CN102653530A (en) * 2011-03-04 2012-09-05 浙江省医学科学院 Preparation method and application of benzofuran derivate
HUP1100165A2 (en) 2011-03-29 2012-12-28 Sanofi Sa Process for preparation of dronedarone by n-butylation
HUP1100167A2 (en) 2011-03-29 2012-11-28 Sanofi Sa Process for preparation of dronedarone by mesylation
WO2013014479A1 (en) * 2011-07-26 2013-01-31 Sanofi Reductive animation process for preparation of dronedarone using aldehyde intermediary compound
WO2013014478A1 (en) * 2011-07-26 2013-01-31 Sanofi Reductive amination process for preparation of dronedarone using carboxyl intermediary compound
FR2983198B1 (en) * 2011-11-29 2013-11-15 Sanofi Sa PROCESS FOR THE PREPARATION OF 5-AMINO-BENZOYL-BENZOFURAN DERIVATIVES
EP2617718A1 (en) 2012-01-20 2013-07-24 Sanofi Process for preparation of dronedarone by the use of dibutylaminopropanol reagent
US9221778B2 (en) 2012-02-13 2015-12-29 Sanofi Process for preparation of dronedarone by removal of hydroxyl group
WO2013121234A1 (en) 2012-02-14 2013-08-22 Sanofi Process for the preparation of dronedarone by oxidation of a sulphenyl group
WO2013124745A1 (en) 2012-02-22 2013-08-29 Sanofi Process for preparation of dronedarone by oxidation of a hydroxyl group
WO2013178337A1 (en) 2012-05-31 2013-12-05 Sanofi Process for preparation of dronedarone by grignard reaction

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2665444B1 (en) * 1990-08-06 1992-11-27 Sanofi Sa AMINO-BENZOFURAN, BENZOTHIOPHENE OR INDOLE DERIVATIVES, THEIR PREPARATION PROCESS AND THE COMPOSITIONS CONTAINING THEM.
FR2817864B1 (en) 2000-12-11 2003-02-21 Sanofi Synthelabo METHANESULFONAMIDO-BENZOFURANE DERIVATIVE, ITS PREPARATION METHOD AND ITS USE AS A SYNTHESIS INTERMEDIATE
FR2817865B1 (en) 2000-12-11 2005-02-18 Sanofi Synthelabo AMINOALKOXYBENZOYLE DERIVATIVE IN SALT FORM, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF AS SYNTHESIS INTERMEDIATE
IL146389A0 (en) * 2001-11-08 2002-07-25 Isp Finetech Ltd Process for the preparation of dronedarone
FR2833262A1 (en) 2001-12-06 2003-06-13 Rhodia Chimie Sa PROCESS FOR MONOSULFONYLATION OF AN AMINOBENZOFURANNE OR AMINOBENZOTHIOPHENE COMPOUND
DE10237819A1 (en) 2002-08-19 2004-03-04 Bayer Ag 5-Nitrobenzofurane
CN101153012B (en) * 2006-09-29 2010-06-23 北京德众万全药物技术开发有限公司 Novel method of producing dronedarone key intermediate
UY32656A (en) 2009-05-27 2010-12-31 Sanofi Aventis PROCEDURE TO PRODUCE BENZOFURANS
TW201111354A (en) 2009-05-27 2011-04-01 Sanofi Aventis Process for the production of Dronedarone intermediates
HUP0900759A2 (en) * 2009-12-08 2011-11-28 Sanofi Aventis Novel process for producing dronedarone
HUP1000010A2 (en) 2010-01-08 2011-11-28 Sanofi Sa Process for producing dronedarone
FR2957079B1 (en) 2010-03-02 2012-07-27 Sanofi Aventis PROCESS FOR THE SYNTHESIS OF CETOBENZOFURAN DERIVATIVES
FR2958290B1 (en) 2010-03-30 2012-10-19 Sanofi Aventis PROCESS FOR THE PREPARATION OF SULFONAMIDO-BENZOFURAN DERIVATIVES
FR2958291B1 (en) 2010-04-01 2013-07-05 Sanofi Aventis PROCESS FOR PREPARING AMINO-BENZOFURAN DERIVATIVES
HUP1000330A2 (en) 2010-06-18 2011-12-28 Sanofi Sa Process for the preparation of dronedarone and the novel intermediates
FR2962731B1 (en) 2010-07-19 2012-08-17 Sanofi Aventis PROCESS FOR THE PREPARATION OF AMINO-BENZOYL-BENZOFURAN DERIVATIVES
FR2963006B1 (en) 2010-07-21 2013-03-15 Sanofi Aventis PROCESS FOR THE PREPARATION OF NITRO-BENZOFURAN DERIVATIVES
HUP1000386A2 (en) 2010-07-22 2012-05-29 Sanofi Sa Novel process for producing dronedarone
FR2973027A1 (en) 2011-03-24 2012-09-28 Sanofi Aventis PROCESS FOR THE SYNTHESIS OF CETOBENZOFURAN DERIVATIVES
HUP1100165A2 (en) 2011-03-29 2012-12-28 Sanofi Sa Process for preparation of dronedarone by n-butylation
HUP1100167A2 (en) 2011-03-29 2012-11-28 Sanofi Sa Process for preparation of dronedarone by mesylation
HUP1100166A2 (en) 2011-03-29 2012-12-28 Sanofi Sa Reductive amination process for preparation of dronedarone using amine intermediary compound

Also Published As

Publication number Publication date
US8501971B2 (en) 2013-08-06
WO2011070380A1 (en) 2011-06-16
EP2509971A1 (en) 2012-10-17
US8889734B2 (en) 2014-11-18
MX2012006654A (en) 2012-06-25
IL220170A0 (en) 2012-07-31
JP2013512944A (en) 2013-04-18
HUP0900759A2 (en) 2011-11-28
BR112012013753A2 (en) 2015-09-15
AU2010329655A1 (en) 2012-06-21
US20120289717A1 (en) 2012-11-15
CN102741238A (en) 2012-10-17
US20130261321A1 (en) 2013-10-03
AU2010329655B2 (en) 2014-01-16
TW201144291A (en) 2011-12-16
CA2781647A1 (en) 2011-06-16
RU2012128568A (en) 2014-01-20
SG181562A1 (en) 2012-07-30
UY33094A (en) 2011-07-29
HU0900759D0 (en) 2010-01-28

Similar Documents

Publication Publication Date Title
AR079269A1 (en) PROCEDURE FOR THE PREPARATION OF DRONEDARONA
AR082296A1 (en) PROCEDURE FOR THE PREPARATION OF DRONEDARONA
AR068403A1 (en) PROCESS AND INTERMEDIARIES FOR THE PREPARATION OF INTEGRASA INHIBITORS
CY1123817T1 (en) METHOD OF PREPARING COMPOUNDS USEFUL AS SGLT INHIBITORS
CO7081155A2 (en) Serine / Threonine Kinase Inhibitors
AR079843A1 (en) PROCEDURE FOR THE PREPARATION OF DRONEDARONA
BR112016006395A2 (en) floating wind turbine support system
AR063449A1 (en) CHEMICAL PROCESS FOR QUINAZOLINE DERIVATIVES, INTERMEDIARIES
UA106611C2 (en) Inhibitors of potassium channels external medullary kidney
MA48798B1 (en) OZANIMOD PRODUCTION PROCESS
RU2018132264A (en) INTERMEDIATE PRODUCTS IN ERYBULIN SYNTHESIS AND RELATED SYNTHESIS METHODS
NZ605444A (en) Salt and solvates of a tetrahydroisoquinoline derivative
AR080656A1 (en) SYNTHESIS OF MAGNOLOL AND ITS ANALOG COMPOUNDS, AND PHARMACEUTICAL COMPOSITION
ES2578377A1 (en) Modulator composites of the calcium dream neural sensor and its therapeutic uses. (Machine-translation by Google Translate, not legally binding)
AR115273A1 (en) METHOD FOR THE PREPARATION OF PHENOXICARBOXYLIC ACID HERBICIDE
NZ728643A (en) Efficient and scalable synthesis of 2-(1’h-indole-3’-carbonyl)-thiazole-4-carboxylic acid methyl ester and its structural analogs
AR113800A1 (en) PROCESS FOR BENZOYL FORMIC ACID COMPOUND AND PYRIDAZINE COMPOUND
BR112017021277A2 (en) SYNTHESIS OF 1- [2- (2,4-DIMETHYL-PHENYLSULFANYL) -FENY] PYPERAZINE
AR101319A1 (en) QUIRAL RESOLUTION OF THE ESTERS OF THE ACID 4-ARIL-2-TIAZOL-2-IL-1,4-DIHYDROPIRIMIDIN-5-CARBOXYL
ES2611776T3 (en) Use of tungsten salts (VI) for the treatment of female sterility in non-diabetic mammals
JP2014517037A5 (en)
AR088775A1 (en) PRIMARY AMINE DIAZENIODIOLATE DIAZENIODIOLATE DERIVATIVES
ECSP066867A (en) PROCESS TO PREPARE DERIVATIVES OF N-ARIL-PIPERAZINA
AR099475A1 (en) ESPIRO-OXAZOLONAS
AR062638A1 (en) Phenyloxyaniline derivatives

Legal Events

Date Code Title Description
FB Suspension of granting procedure